The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

Independent drugstores are closing at an alarming rate — about one a day in 2023 — squeezed by the huge companies that ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

The Biden administration said a record 24.2 million Americans enrolled in individual coverage under the Affordable Care Act ...

Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...

Providers, patients and even some federal judges say progress-based insurance denials harm patients at key moments of mental ...

UnitedHealth Group Incorporated (NYSE:UNH) dropped its share prices by 6.04 percent on Thursday to end at $510.59 apiece ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.